accuRx raises £27.5m in funding to help enlargement

Healthcare communication platform accuRx has secured £27.5million in funding which can go in the direction of increasing the corporate and serving to construct extra merchandise. 

The corporate partnered with Lakestar, who led the Sequence B funding spherical, and with present traders persevering with with their help and British Affected person Capital was welcomed as a brand new investor.

In keeping with the corporate, 98% of GP practices are already utilizing accuRx’s core merchandise to speak with sufferers – together with its Chain SMS textual content service. It’s now specializing in constructing a patient-centred platform to make sure that everybody concerned in a affected person’s care can talk with one another.

Writing in a blog post, Laurence Bargery, co-founder of accuRx, stated: “Product-wise, we wish to go deeper into GP practices to supply extra worth and broaden our providing into secondary care. Healthcare is complicated, and requires leaps of religion at occasions.

“Now we have some sturdy beliefs about our product roadmap, however a few of the choices we take will likely be improper and a few might be fairly expensive when it comes to time spent. We hope this funding permits us to double down on making our present merchandise even higher, in addition to taking some massive bets.

“If a few of these massive bets come off, we’ll actually improve the influence we now have.”

The corporate desires to develop the adoption of the expertise into hospital and care residence settings to attach communication throughout the well being and social care system. The funding will even be used for enhancing present merchandise, rising the staff and increasing workplace house.

Bargery concluded: “We’ve constructed an amazing basis and we’re constructing merchandise quick and at scale, that are extremely dependable and user-focused. We’ve bought an thrilling roadmap to ship extra worth to common apply and develop our adoption throughout the healthcare system.”

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button